Löschmann, P A <br/><br/>
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease.  [electronic resource] 

 -  Journal of neural transmission. Parkinson's disease and dementia section  1991 
 - 203-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0936-3076 
<br/><br/><label>Standard No.: </label>10.1007/BF02259538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Callithrix<br/>Disease Models, Animal<br/>Drug Synergism<br/>Ibotenic Acid--analogs & derivatives<br/>Levodopa--pharmacology<br/>Male<br/>Motor Activity--drug effects<br/>Oxidopamine--pharmacology<br/>Parkinson Disease, Secondary--drug therapy<br/>Piperazines--pharmacology<br/>Quinoxalines--pharmacology<br/>Rats<br/>Rats, Inbred Strains<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Substantia Nigra--drug effects<br/>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid